Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Psychotropic treatment of Autism
Stefano Pallanti
, Lorenza Bencini
, Andrea Cantisani
, Eric Hollander
Friedman Brain Institute
Icahn School of Medicine at Mount Sinai
Psychiatry
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Psychotropic treatment of Autism'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Autism Treatment
100%
Therapist
100%
Psychiatrists
50%
Antipsychotics
50%
Pharmacological Approaches
50%
Antidepressants
50%
Educational Intervention
50%
Multidisciplinary Team
50%
Psychologists
50%
Behavioral Intervention
50%
Neurologist
50%
Autism
50%
Childhood Autism
50%
Pharmacological Treatment
50%
Anxiolytic
50%
Adolescents with Autism Spectrum Disorder
50%
Psychostimulants
50%
Rehabilitative Intervention
50%
Multimodal Intervention
50%
Other Pervasive Developmental Disorders
50%
Non-medical Treatment
50%
Occupational Language
50%
Neuroscience
Psychoactive Drug
100%
Autism
100%
Autism Spectrum Disorder
100%
Antidepressant
50%
Psychostimulant
50%
Anxiolytic
50%
Pharmacology, Toxicology and Pharmaceutical Science
Psychotropic Agent
100%
Autism
100%
Antidepressant
33%
Psychostimulant
33%
Developmental Disorder
33%
Anxiolytic
33%
Psychology
Autism Spectrum Disorder
100%
Autism
100%
Adolescence
50%
Psychologist
50%